Sponsor or institution
Clinical trials and research at Vigonvita Life Sciences
As of November 12, 2026, Find a Trial lists 7 clinical trials run by Vigonvita Life Sciences that are recruiting, in China. By phase: Phase 1 (5), Early Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Safety and Pharmacokinetics of VV261 Tablets in Healthy Adults | Phase 1 | Hefei, Anhui | Recruiting | Jul 17, 2026 |
| How VV913 behaves after different meals in healthy adults | Phase 1 | Hefei, Anhui | Recruiting | May 4, 2026 |
| Safety and dosing of VV913 capsules in healthy adults | Early Phase 1 | Hefei, Anhui | Recruiting | Apr 2, 2026 |
| Safety, tolerability, and dosing of VV913 capsules in healthy Chinese men | Phase 1 | Hefei, Anhui | Recruiting | Jan 28, 2026 |
| How a standard meal affects VV119 capsules in healthy adults | Phase 1 | Hefei, Anhui | Recruiting | Nov 21, 2025 |
| Evaluating LV232 Capsules for Treating Major Depressive Disorder | Phase 2 | Shanghai | Recruiting | Feb 17, 2025 |
| Evaluating the safety and effects of VV119 in schizophrenia patients | Phase 1 | Beijing, Beijing Municipality and 3 other locations | Recruiting | Jul 16, 2024 |
All recruiting trials (7)
-
Safety and Pharmacokinetics of VV261 Tablets in Healthy Adults
This study tests how VV261 tablets behave and how safe they are in healthy adults, using a random, placebo-controlled design with escalating doses.
-
How VV913 behaves after different meals in healthy adults
This study tests how a single dose of VV913 is absorbed in healthy adult men when taken with a high-fat meal versus a standard meal.
-
Safety and dosing of VV913 capsules in healthy adults
This study tests different doses of VV913 to see if it is safe and how it behaves in the body for healthy adult men in China.
-
Safety, tolerability, and dosing of VV913 capsules in healthy Chinese men
This test gives single, increasing doses of VV913 or placebo to healthy Chinese men aged 18–45 to see if the drug is safe and how the body processes it.
-
How a standard meal affects VV119 capsules in healthy adults
Researchers will test whether eating a standard meal changes how VV119 capsules are absorbed in healthy adult volunteers.
-
Evaluating LV232 Capsules for Treating Major Depressive Disorder
This study is testing different doses of LV232 capsules to see if they can help people with major depressive disorder feel better compared to a placebo and an active medication.
-
Evaluating the safety and effects of VV119 in schizophrenia patients
This study is testing a new drug called VV119 to see if it is safe and effective for adults with schizophrenia.
Quick answers
How many clinical trials run by Vigonvita Life Sciences are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 5, Early Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.